Onset of Effect, Changes in Airflow Obstruction and Lung Volume, and Health-Related Quality of Life Improvements with Benralizumab for Patients with Severe Eosinophilic Asthma: Phase IIIb Randomized, Controlled Trial (SOLANA) [Corrigendum]

Onset of Effect, Changes in Airflow Obstruction and Lung Volume, and Health-Related Quality of Life Improvements with Benralizumab for Patients with Severe Eosinophilic Asthma: Phase IIIb Randomized, Controlled Trial (SOLANA) [Corrigendum]

Panettieri RA Jr, Welte T, Shenoy KV, et al. J Asthma Allergy. 2020;13:115–126.The authors have advised that the symbol shown on page 124, discussion section, left column, line 5 “≥20%” should read “<20%”.Read the orig...

Full description

Bibliographic Details
Main Authors: Panettieri RA Jr, Welte T, Shenoy KV, Korn S, Jandl M, Kerwin EM, Feijoo R, Barker P, Olsson RF, Martin UJ
Format: Article
Language:English
Published: Dove Medical Press 2020-03-01
Series:Journal of Asthma and Allergy
Subjects:
anti–il-5rα
benralizumab
interleukin-5
randomized controlled trial
eosinophilic
severe asthma 
Online Access:https://www.dovepress.com/corrigendum-onset-of-effect-changes-in-airflow-obstruction-and-lung-vo-peer-reviewed-article-JAA

Internet

https://www.dovepress.com/corrigendum-onset-of-effect-changes-in-airflow-obstruction-and-lung-vo-peer-reviewed-article-JAA

Similar Items